0000899243-22-011663.txt : 20220318 0000899243-22-011663.hdr.sgml : 20220318 20220318211539 ACCESSION NUMBER: 0000899243-22-011663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220316 FILED AS OF DATE: 20220318 DATE AS OF CHANGE: 20220318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reich Samuel J CENTRAL INDEX KEY: 0001394645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 22754052 MAIL ADDRESS: STREET 1: ACUITY PHARMACEUTICALS INC STREET 2: 3701 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-16 0 0001833214 SAB Biotherapeutics, Inc. SABS 0001394645 Reich Samuel J 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104 1 1 0 0 Executive Chairman Employee Stock Option (right to buy) 1.78 2022-03-16 4 A 0 7000 0.00 A 2032-03-16 Common Stock 7000 7000 D Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. The shares underlying the option will vest in full on the one-year anniversary of March 16, 2022, the date the award was approved by the Company's board of directors. /s/ Samuel J. Reich 2022-03-18